摘要
背景:阿尔茨海默病(AD)是一种常见的蛋白错误折叠进行性神经退行性疾病,是痴呆的最常见形式之一。淀粉样蛋白前体蛋白(APP)衍生的淀粉样蛋白(Aβ)蛋白积累到神经元间隙中,并在疾病进展及其病理中起关键作用。聚集的Aβ通过诱导神经元细胞凋亡和氧化损伤发挥其神经毒性作用。 目的:我们研究了合成的前药肽(PDp)对人神经母细胞瘤SH-SY5Y细胞中Aβ1-40诱导的细胞毒性的影响,代表了对抗人AD中最有效的策略之一。 方法:用Aβ1-40处理细胞,在AD实验模型中诱导细胞毒作用,筛选PDp的抑制作用。通过Western印迹评估细胞活力,活性氧(ROS)产生,细胞内游离Ca 2+水平和关键凋亡蛋白表达的测定。 结果:我们的研究结果表明,Aβ1-40诱导24h导致细胞活力降低,Ca2 +稳态失衡,神经元凋亡增加。 PDp治疗可有效改善Aβ1-40诱导的神经毒性,并通过Bcl-2,Bax,Caspase-3活性和细胞色素c等途径减弱ROS介导的细胞凋亡信号传导。 结论:这些研究结果表明,PDp具有潜在的作用,作为一个神经保护和治疗剂对抗人类AD。
关键词: 阿尔茨海默病,淀粉状蛋白-β,凋亡,前药肽,活性氧,SH-SY5Y细胞。
Current Alzheimer Research
Title:A Peptide Based Pro-Drug Ameliorates Amyloid-β Induced Neuronal Apoptosis in In Vitro SH-SY5Y Cells
Volume: 14 Issue: 12
关键词: 阿尔茨海默病,淀粉状蛋白-β,凋亡,前药肽,活性氧,SH-SY5Y细胞。
摘要: Background: Alzheimer's disease (AD), a common protein misfolding progressive neurodegenerative disorder, is one of the most common forms of dementia. Amyloid precursor protein (APP) derived amyloid-β (Aβ) protein accumulate into interneuronal spaces and plays a crucial role in the disease progression and its pathology. The aggregated Aβ exerts its neurotoxic effects by inducing apoptosis and oxidative damage in neuronal cells.
Objectives: We have investigated the effects of a synthesized Pro-Drug peptide (PDp) on Aβ1-40 induced cytotoxicity in human neuroblastoma SH-SY5Y cells, represents one of the most effective strategies in combating human AD.
Methods: Cells were treated with Aβ1-40 to induce cytotoxicity in the experimental model of AD to screen the inhibitory effect of PDp. Assays for cell viability, reactive oxygen species (ROS) generation, levels of intracellular free Ca2+ and expression of key apoptotic proteins were assessed by Western Blotting.
Results: Our results showed that Aβ1-40 induces for 24h caused reduce cell viability, imbalance in Ca2+ homeostasis and increase in neuronal apoptosis in vitro. Treatment with PDp could effectively ameliorated Aβ1-40 induced neurotoxicity and attenuates ROS generation that mediates apoptotic signaling through Bcl-2, Bax, Caspase-3 activity and cytochrome c in the cells.
Conclusion: These findings suggested that PDp has potential role as a neuroprotective and therapeutic agent for combating human AD.
Export Options
About this article
Cite this article as:
A Peptide Based Pro-Drug Ameliorates Amyloid-β Induced Neuronal Apoptosis in In Vitro SH-SY5Y Cells, Current Alzheimer Research 2017; 14 (12) . https://dx.doi.org/10.2174/1567205014666170713153414
DOI https://dx.doi.org/10.2174/1567205014666170713153414 |
Print ISSN 1567-2050 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5828 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Endocytosis, Intracellular Traffic and Fate of Cell Penetrating Peptide Based Conjugates and Nanoparticles
Current Pharmaceutical Design Multicomponent 1,3-Dipolar Cycloaddition Reactions in the Construction of Hybrid Spiroheterocycles
Current Organic Chemistry Natural Molecules as Talented Inhibitors of Nucleotide Pyrophosphatases/ Phosphodiesterases (PDEs)
Current Topics in Medicinal Chemistry Gene and Cancer Therapy - Pseudorabies Virus: A Novel Research and Therapeutic Tool?
Current Gene Therapy Dual Targeting of Glioma U251 Cells with Nanoparticles Prevents Tumor Angiogenesis and Inhibits Tumor Growth
Current Neurovascular Research Cancer Vaccines: Emphasis on Pediatric Cancers
Current Pharmaceutical Design Cyclin Dependent Kinase 1 Inhibitors: A Review of Recent Progress
Current Medicinal Chemistry The Therapeutic Target Hsp90 and Cancer Hallmarks
Current Pharmaceutical Design A Pan-Cancer Review of <i>ALK</i> Mutations: Implications for Carcinogenesis and Therapy
Current Cancer Drug Targets The Role of Traditional Chinese Herbal Medicines and Bioactive Ingredients on Ion Channels: A Brief Review and Prospect
CNS & Neurological Disorders - Drug Targets Targeting Class IIa HDACs: Insights from Phenotypes and Inhibitors
Current Medicinal Chemistry HIF-1α and Calcium Signaling as Targets for Treatment of Prostate Cancer by Cardiac Glycosides
Current Cancer Drug Targets α-Synuclein Misfolding and Neurodegenerative Diseases
Current Protein & Peptide Science Induced Pluripotent Stem Cells as a Model for Accelerated Patient- and Disease-specific Drug Discovery
Current Medicinal Chemistry Protein Modification by β-N-Acetyl Glucosamine (O-GlcNAc) in Insulin Signaling and Insulin Resistance
Recent Patents on Endocrine, Metabolic & Immune Drug Discovery (Discontinued) Early Apoptotic Vascular Signaling is Determined by Sirt1 Through Nuclear Shuttling, Forkhead Trafficking, Bad, and Mitochondrial Caspase Activation
Current Neurovascular Research Role of the APP Non-Amyloidogenic Signaling Pathway and Targeting α-Secretase as an Alternative Drug Target for Treatment of Alzheimers Disease
Current Medicinal Chemistry Implication of Green Tea as a Possible Therapeutic Approach for Parkinson Disease
CNS & Neurological Disorders - Drug Targets Up-Regulation of Hypoxia-Inducible Factor (HIF)-1α and HIF-Target Genes in Cortical Neurons by the Novel Multifunctional Iron Chelator Anti-Alzheimer Drug, M30
Current Alzheimer Research Prospective Teratology of Retinoic Acid Metabolic Blocking Agents (RAMBAs) and Loss of CYP26 Activity
Current Pharmaceutical Design